ResMed Buy Hold or Sell Recommendation

RMD -- USA Stock  

USD 112.93  2.17  1.96%

Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding ResMed is 'Strong Buy'. Macroaxis provides ResMed buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ResMed positions. The advice algorithm takes into account all of ResMed available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from ResMed buy-and-hold prospective. Additionally take a look at ResMed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell ResMedBuy ResMed
Strong Buy

Volatility

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

Inapplicable
For the selected time horizon ResMed has a risk adjusted performance of 0.0862, jensen alpha of 0.2061, total risk alpha of 0.3127, sortino ratio of 0.1621 and treynor ratio of 0.1522
Macroaxis provides advice on ResMed to complement and cross-verify current analyst consensus on ResMed. Our recommendation engine determines the corporation potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure ResMed is not overpriced, please check all ResMed fundamentals including its Revenue, Current Ratio, Market Capitalization, as well as the relationship between Cash and Equivalents and Earnings Per Share . Given that ResMed has Price to Earning of 49.71X, we recommend you check out ResMed market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your recent risk tolerance and investing horizon.

ResMed Thematic Classifications

Obamacare Repeal IdeaObamacare Repeal
Large healthcare related equities associated with Obamacare

ResMed Returns Distribution Density

Mean Return0.11Value At Risk2.13
Potential Upside2.65Standard Deviation1.72
 Return Density 
      Distribution 

ResMed Greeks

α
Alpha over DOW
=0.21
β
Beta against DOW=0.65
σ
Overall volatility
=1.73
Ir
Information ratio =0.15

ResMed Volatility Alert

ResMed has relatively low volatility with skewness of 0.65 and kurtosis of 1.25. However, we advise all investors to independently investigate ResMed to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.
    
 Better Than Average     
    
 Worse Than Average Compare ResMed to competition

ResMed Fundamental Vs Peers

FundamentalsResMedPeer Average
Return On Equity16.97% (15.17)%
Return On Asset11.28% (15.64)%
Profit Margin13.94% (5.50)%
Operating Margin29.63% (10.91)%
Current Valuation15.97B152.14B
Shares Outstanding142.5M1.43B
Shares Owned by Insiders1.24% 6.91%
Shares Owned by Institutions67.99% 18.37%
Number of Shares Shorted2.49M3.24M
Price to Earning49.71X40.69X
Price to Book8.65X14.44X
Price to Sales6.83X17.81X
Revenue2.4B9.85B
Gross Profit1.36B21.75B
EBITDA712.65M1.41B
Net Income335.2M517.71M
Cash and Equivalents230.19M3.89B
Cash per Share1.62X5.17X
Total Debt529.61M7.36B
Debt to Equity27.80% 0.72%
Current Ratio2.58X3.30X
Book Value Per Share13.34X13.64X
Cash Flow from Operations502.03M1.25B
Short Ratio3.13X2.09X
Earnings Per Share2.32X2.30X
Price to Earnings To Growth4.08X1.22X
Number of Employees6K10.67K
Beta1.20.34
Market Capitalization16.43B29.78B
Total Asset3.26B126.86B
Retained Earnings2.16B38.24B
Working Capital781.73M3.58B
Current Asset1.42B36.8B
   Sale by Hollingshead James of 600 shares of ResMed [view details]

ResMed Alerts

Trading Alerts and Improvement Suggestions

About 68.0% of the company shares are owned by institutional investors

Latest Analysts View

ResMed Current Analysts Recommendations

Target Median Price115.90
Target Mean Price107.13
Recommendation Mean2.50
Target High Price127.00
Number Of Analyst Opinions7
Target Low Price75.00
Additionally take a look at ResMed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool. Please also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. drill down to check world indexes.
Search macroaxis.com